Our InCell ELISA results reveal that both Her2-negative MCF-7 and Her2-positive SK-BR3 breast cancer cell lines exhibit comparable baseline expression of CD63, a canonical exosomal marker indicative of active exosomal biogenesis. Here, ERBB2 is linked to breast carcinoma.